• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

编码和非编码RNA变异在癌症中的作用及机制

The roles and mechanisms of coding and noncoding RNA variations in cancer.

作者信息

Kim Sang Yean, Na Min Jeong, Yoon Sungpil, Shin Eunbi, Ha Jin Woong, Jeon Soyoung, Nam Suk Woo

机构信息

Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Functional RNomics Research Center, The Catholic University of Korea, Seoul, Republic of Korea.

出版信息

Exp Mol Med. 2024 Sep;56(9):1909-1920. doi: 10.1038/s12276-024-01307-x. Epub 2024 Sep 2.

DOI:10.1038/s12276-024-01307-x
PMID:39218979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11447202/
Abstract

Functional variations in coding and noncoding RNAs are crucial in tumorigenesis, with cancer-specific alterations often resulting from chemical modifications and posttranscriptional processes mediated by enzymes. These RNA variations have been linked to tumor cell proliferation, growth, metastasis, and drug resistance and are valuable for identifying diagnostic or prognostic cancer biomarkers. The diversity of posttranscriptional RNA modifications, such as splicing, polyadenylation, methylation, and editing, is particularly significant due to their prevalence and impact on cancer progression. Additionally, other modifications, including RNA acetylation, circularization, miRNA isomerization, and pseudouridination, are recognized as key contributors to cancer development. Understanding the mechanisms underlying these RNA modifications in cancer can enhance our knowledge of cancer biology and facilitate the development of innovative therapeutic strategies. Targeting these RNA modifications and their regulatory enzymes may pave the way for novel RNA-based therapies, enabling tailored interventions for specific cancer subtypes. This review provides a comprehensive overview of the roles and mechanisms of various coding and noncoding RNA modifications in cancer progression and highlights recent advancements in RNA-based therapeutic applications.

摘要

编码RNA和非编码RNA的功能变异在肿瘤发生过程中至关重要,癌症特异性改变通常源于化学修饰以及由酶介导的转录后过程。这些RNA变异与肿瘤细胞的增殖、生长、转移和耐药性相关,对于识别癌症诊断或预后生物标志物具有重要价值。转录后RNA修饰的多样性,如剪接、多聚腺苷酸化、甲基化和编辑,因其普遍性及其对癌症进展的影响而尤为显著。此外,其他修饰,包括RNA乙酰化、环化、miRNA异构化和假尿苷化,也被认为是癌症发展的关键因素。了解癌症中这些RNA修饰的潜在机制,可以增进我们对癌症生物学的认识,并促进创新治疗策略的开发。针对这些RNA修饰及其调控酶可能为新型基于RNA的疗法铺平道路,从而能够针对特定癌症亚型进行个性化干预。本综述全面概述了各种编码和非编码RNA修饰在癌症进展中的作用和机制,并重点介绍了基于RNA的治疗应用的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda3/11447202/bbac7fb1f706/12276_2024_1307_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda3/11447202/63e01e14b333/12276_2024_1307_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda3/11447202/52e288987854/12276_2024_1307_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda3/11447202/bbac7fb1f706/12276_2024_1307_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda3/11447202/63e01e14b333/12276_2024_1307_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda3/11447202/52e288987854/12276_2024_1307_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda3/11447202/bbac7fb1f706/12276_2024_1307_Fig3_HTML.jpg

相似文献

1
The roles and mechanisms of coding and noncoding RNA variations in cancer.编码和非编码RNA变异在癌症中的作用及机制
Exp Mol Med. 2024 Sep;56(9):1909-1920. doi: 10.1038/s12276-024-01307-x. Epub 2024 Sep 2.
2
The interplay between m6A RNA methylation and noncoding RNA in cancer.m6A RNA 甲基化与癌症中非编码 RNA 的相互作用。
J Hematol Oncol. 2019 Nov 22;12(1):121. doi: 10.1186/s13045-019-0805-7.
3
Posttranscriptional Regulation by Proteins and Noncoding RNAs.蛋白质和非编码 RNA 的转录后调控。
Adv Exp Med Biol. 2024;1441:313-339. doi: 10.1007/978-3-031-44087-8_17.
4
Epitranscriptomics and cervical cancer: the emerging role of mA, mC and mA RNA modifications.表观转录组学与宫颈癌:m~A、m~C 和 m~A RNA 修饰的新兴作用。
Expert Rev Mol Med. 2024 Oct 8;26:e20. doi: 10.1017/erm.2024.20.
5
Modifications of RNA in cancer: a comprehensive review.癌症中RNA的修饰:全面综述
Mol Biol Rep. 2025 Mar 17;52(1):321. doi: 10.1007/s11033-025-10419-0.
6
Posttranscriptional methylation of transfer and ribosomal RNA in stress response pathways, cell differentiation, and cancer.应激反应途径、细胞分化和癌症中转运RNA和核糖体RNA的转录后甲基化
Curr Opin Oncol. 2016 Jan;28(1):65-71. doi: 10.1097/CCO.0000000000000252.
7
A mark of disease: how mRNA modifications shape genetic and acquired pathologies.疾病的标志:mRNA 修饰如何影响遗传和获得性疾病。
RNA. 2021 Apr;27(4):367-389. doi: 10.1261/rna.077271.120. Epub 2020 Dec 29.
8
Interplay between regulation by methylation and noncoding RNAs in cancers.癌症中甲基化调控与非编码RNA之间的相互作用。
Eur J Cancer Prev. 2018 Jul;27(4):418-424. doi: 10.1097/CEJ.0000000000000433.
9
The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression.m6A 修饰与肿瘤微环境中非编码 RNA 的相互作用对癌症进展的影响。
Int Immunopharmacol. 2024 Oct 25;140:112824. doi: 10.1016/j.intimp.2024.112824. Epub 2024 Aug 6.
10
RNA in cancer.癌症中的 RNA。
Nat Rev Cancer. 2021 Jan;21(1):22-36. doi: 10.1038/s41568-020-00306-0. Epub 2020 Oct 20.

引用本文的文献

1
Single-Cell Transcriptomic Approaches for Decoding Non-Coding RNA Mechanisms in Colorectal Cancer.用于解码结直肠癌中非编码RNA机制的单细胞转录组学方法
Noncoding RNA. 2025 Mar 10;11(2):24. doi: 10.3390/ncrna11020024.
2
Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review).长链非编码RNA在致癌作用中的表观遗传和表转录组学作用(综述)
Int J Oncol. 2025 Apr;66(4). doi: 10.3892/ijo.2025.5735. Epub 2025 Feb 28.
3
Interplay of Transcriptomic Regulation, Microbiota, and Signaling Pathways in Lung and Gut Inflammation-Induced Tumorigenesis.

本文引用的文献

1
Splicing regulation through biomolecular condensates and membraneless organelles.通过生物分子凝聚物和无膜细胞器进行剪接调控。
Nat Rev Mol Cell Biol. 2024 Sep;25(9):683-700. doi: 10.1038/s41580-024-00739-7. Epub 2024 May 21.
2
Classification, function, and advances in tsRNA in non-neoplastic diseases.非肿瘤性疾病中 tsRNA 的分类、功能及研究进展。
Cell Death Dis. 2023 Nov 16;14(11):748. doi: 10.1038/s41419-023-06250-9.
3
Long non-coding RNA generated from CDKN1A gene by alternative polyadenylation regulates p21 expression during DNA damage response.
肺和肠道炎症诱导肿瘤发生过程中转录组调控、微生物群与信号通路的相互作用
Cells. 2024 Dec 24;14(1):1. doi: 10.3390/cells14010001.
长非编码 RNA 通过选择性多聚腺苷酸化由 CDKN1A 基因产生,在 DNA 损伤反应过程中调节 p21 的表达。
Nucleic Acids Res. 2023 Nov 27;51(21):11911-11926. doi: 10.1093/nar/gkad899.
4
Super Enhancer-Regulated LncRNA LINC01089 Induces Alternative Splicing of DIAPH3 to Drive Hepatocellular Carcinoma Metastasis.超级增强子调控的长链非编码 RNA LINC01089 诱导 DIAPH3 的可变剪接从而驱动肝癌转移。
Cancer Res. 2023 Dec 15;83(24):4080-4094. doi: 10.1158/0008-5472.CAN-23-0544.
5
RNA modifications in physiology and disease: towards clinical applications.RNA 修饰在生理和疾病中的作用:迈向临床应用。
Nat Rev Genet. 2024 Feb;25(2):104-122. doi: 10.1038/s41576-023-00645-2. Epub 2023 Sep 15.
6
The strict regulation of HIF-1α by non-coding RNAs: new insight towards proliferation, metastasis, and therapeutic resistance strategies.非编码 RNA 对 HIF-1α 的严格调控:增殖、转移和治疗抵抗策略的新见解。
Cancer Metastasis Rev. 2024 Mar;43(1):5-27. doi: 10.1007/s10555-023-10129-8. Epub 2023 Aug 8.
7
Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma.鉴定和验证与 m7G 相关的 lncRNA 特征,以预测肝细胞癌的预后和治疗反应。
PLoS One. 2023 Aug 3;18(8):e0289552. doi: 10.1371/journal.pone.0289552. eCollection 2023.
8
Long non-coding RNA-targeting therapeutics: discovery and development update.靶向长链非编码RNA的疗法:发现与开发进展
Expert Opin Drug Discov. 2023 Jul-Dec;18(9):1011-1029. doi: 10.1080/17460441.2023.2236552. Epub 2023 Jul 20.
9
Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues.m6A 与癌症中编码/非编码 RNA 的串扰及其修饰残基的检测方法。
Aging (Albany NY). 2023 Jul 11;15(13):6577-6619. doi: 10.18632/aging.204836.
10
Emerging roles of tRNA-derived small RNAs in cancer biology.tRNA 衍生的小 RNA 在癌症生物学中的新兴作用。
Exp Mol Med. 2023 Jul;55(7):1293-1304. doi: 10.1038/s12276-023-01038-5. Epub 2023 Jul 10.